Roche Holding AG
F:RHO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Roche Holding AG
F:RHO
|
CH |
|
G
|
Ganges Securities Ltd
NSE:GANGESSECU
|
IN |
|
Zanaga Iron Ore Company Ltd
LSE:ZIOC
|
GG |
|
New York Mortgage Trust Inc
NASDAQ:NYMT
|
US |
|
Unifi Inc
NYSE:UFI
|
US |
|
Xtract Resources PLC
LSE:XTR
|
UK |
|
M
|
Mtn Zakhele Futhi (RF) Ltd
JSE:MTNZF
|
ZA |
|
Transrail Lighting Ltd
NSE:TRANSRAILL
|
IN |
|
W
|
West Red Lake Gold Mines Ltd
XTSX:WRLG
|
CA |
|
Suprajit Engineering Ltd
NSE:SUPRAJIT
|
IN |
|
Poligrafici Printing SpA
MIL:POPR
|
IT |
|
Altitude International Holdings Inc
OTC:ALTD
|
US |
|
Mandala Multifinance Tbk PT
IDX:MFIN
|
ID |
|
Jumia Technologies AG
NYSE:JMIA
|
DE |
|
T
|
Trident Digital Tech Holdings Ltd
NASDAQ:TDTH
|
SG |
|
H
|
Haier Smart Home Co Ltd
HKEX:6690
|
CN |
|
W
|
Wildcat Resources Ltd
ASX:WC8
|
AU |
|
H
|
Havas NV
AEX:HAVAS
|
FR |
|
H
|
Harbour-Link Group Bhd
KLSE:HARBOUR
|
MY |
|
K
|
Kelly Services Inc
F:KYSA
|
US |
|
N
|
Nitin Castings Ltd
BSE:508875
|
IN |
|
T
|
Torm PLC
CSE:TRMD A
|
UK |
|
C
|
Converge Information & Communications Technology Solutions Inc
XPHS:CNVRG
|
PH |
|
R
|
RH Bophelo Ltd
JSE:RHB
|
ZA |
Multiples-Based Value
The
Multiples-Based Value for
Roche Holding AG (RHO)
under the Base Case is
hidden
EUR.
Compared with the current market price of 360 EUR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
RHO Competitors Multiples
Roche Holding AG Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
|
Roche Holding AG
F:RHO
|
248.4B EUR | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD | 13.6 | 42.8 | 28.9 | 30.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
235.8B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD | 2.6 | 20.7 | 7.9 | 10.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD | 2.5 | 17 | 7.2 | 8.8 | |
| FR |
|
Sanofi SA
PAR:SAN
|
99.8B EUR | 2.1 | 12.8 | 10.6 | 10.6 |